Additions and updates in November

This month has seen the addition of two new comedications and the updating of three documents in the Prescribing Resources section of the website.

Rolapitant has been added to the Gastrointestinal agents (anti-emetics) class of comedications and telavancin has been added to the Antibacterial comedication class.

In the Prescribing Resources section, the Treatment Selectors for Key COVID-19 Therapies and the "At-a-glance" summary of interactions for COVID-19 antiviral therapies and COVID-19 host-directed therapies have been updated with all recent changes and additions.